Sue Haupt

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Radical Prostatectomy

Endoscopic Submucosal Dissection

Top Venues

Nature medicine

Nature reviews. Cancer

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Cheryl Carcel, Sue Haupt, Clare Arnott, Mei Ling Yap, Amanda Henry, Jane E Hirst, Mark Woodward, Robyn Norton
A life-course approach to tackling noncommunicable diseases in women. Nature medicine 30 (1) (2024)
Cheryl Carcel, Sue Haupt, Clare Arnott, Mei Ling Yap, Amanda Henry, Jane E Hirst, Mark Woodward, Robyn Norton
A life-course approach to tackling noncommunicable diseases in women. Nature medicine 30 (1) (2024)
Cheryl Carcel, Sue Haupt, Clare Arnott, Mei Ling Yap, Amanda Henry, Jane E Hirst, Mark Woodward, Robyn Norton
A life-course approach to tackling noncommunicable diseases in women. Nature medicine 30 (1) (2024)
Cheryl Carcel, Sue Haupt, Clare Arnott, Mei Ling Yap, Amanda Henry, Jane E Hirst, Mark Woodward, Robyn Norton
A life-course approach to tackling noncommunicable diseases in women. Nature medicine 30 (1) (2024)
Cheryl Carcel, Sue Haupt, Clare Arnott, Mei Ling Yap, Amanda Henry, Jane E Hirst, Mark Woodward, Robyn Norton
A life-course approach to tackling noncommunicable diseases in women. Nature medicine (2024)
Cheryl Carcel, Sue Haupt, Clare Arnott, Mei Ling Yap, Amanda Henry, Jane E Hirst, Mark Woodward, Robyn Norton
A life-course approach to tackling noncommunicable diseases in women. Nature medicine 30 (1) (2024)
Franco Caramia, Terence P Speed, Hui Shen, Ygal Haupt, Sue Haupt
Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes. Cells 12 (18) (2023)
Javier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia, Nicholas James Clemons, Kenji M Fujihara, Thomas Riseborough, Amina Teunisse, Aart G Jochemsen, Lars Abrahmsén, Giovanni Blandino, Andrea Russo, Cristina Gamell, Stephen B Fox, Catherine Mitchell, Elena A Takano, David J Byrne, Panimaya Jeffreena Miranda, Reem Saleh, Heather Thorne, Shahneen Sandhu, Scott G Williams, Simon P Keam, Ygal Haupt, Sue Haupt
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status. Cancers 14 (16) (2022)
Javier Octavio Mejía-Hernández, Simon Paul Keam, Reem Saleh, Fenella Muntz, Stephen B Fox, David Byrne, Arielle Kogan, Lokman Pang, Jennifer Huynh, Cassandra Litchfield, Franco Caramia, Guillermina Lozano, Hua He, James M You, Shahneen Sandhu, Scott G Williams, Ygal Haupt, Sue Haupt
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss. Cell death & disease 13 (9) (2022)
Kenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson, Moses Olalekan Ogunkola, Brunda Nijagal, Julia V Milne, David A Sallman, Ching-Seng Ang, Iva Nikolic, Conor J Kearney, Simon J Hogg, Carlos S Cabalag, Vivien R Sutton, Sally Watt, Asuka T Fujihara, Joseph A Trapani, Kaylene J Simpson, Diana Stojanovski, Silke Leimkühler, Sue Haupt, Wayne A Phillips, Nicholas James Clemons
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. Science advances 8 (37) (2022)
Sue Haupt, Franco Caramia, Sabra L Klein, Joshua B Rubin, Ygal Haupt
Sex disparities matter in cancer development and therapy. Nature reviews. Cancer 21 (6) (2021)
Kenji M Fujihara, Mariana Corrales Benitez, Carlos S Cabalag, Bonnie Z Zhang, Hyun Soo Ko, David S Liu, Kaylene J Simpson, Ygal Haupt, Lara Lipton, Sue Haupt, Wayne A Phillips, Nicholas James Clemons
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status. Molecular cancer therapeutics 20 (10) (2021)
Donald Freudenstein, Cassandra Litchfield, Franco Caramia, Gavin Wright, Benjamin J Solomon, David Ball, Simon Paul Keam, Paul Neeson, Ygal Haupt, Sue Haupt
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival. Cancers 12 (6) (2020)
Sue Haupt, Franco Caramia, Alan Herschtal, Thierry Soussi, Guillermina Lozano, Hu Chen, Han Liang, Terence P Speed, Ygal Haupt
Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network. Nature communications 10 (1) (2019)
Jacob T Jackson, Ashley P Ng, Benjamin J Shields, Sue Haupt, Ygal Haupt, Matthew P McCormack
Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice. Blood advances 2 (4) (2019)
Panimaya Jeffreena Miranda, Daniel Buckley, Dinesh Raghu, Jia-Min B Pang, Elena A Takano, Reshma Vijayakumaran, Amina Fas Teunisse, Atara Posner, Tahlia Procter, Marco J Herold, Cristina Gamell, Jean-Christophe Marine, Stephen B Fox, Aart Jochemsen, Sue Haupt, Ygal Haupt
MDM4 is a rational target for treating breast cancers with mutant p53. The Journal of pathology 241 (5) (2017)
Sue Haupt, Ygal Haupt
P53 at the start of the 21st century: lessons from elephants. F1000Research 6 (2017)